The X-Ray Reinvented
Our proprietary, advanced emitter technology platform – Quastar® produces high output and high quality photons more efficiently allowing our partners to improve our quality of life.


Life, it matters to us.
Rad Source irradiator solutions impact the lives of people across the world daily. From improving transplant patient outcomes, advancing cancer and cell research or helping control populations of disease-carrying and crop-destroying insects – Life matters.
What’s the Difference?
Quastar® vs. Traditional X-ray Imaging Tube
When it comes to x-ray field output, beam hardness, uniformity and versatility, the Quastar x-ray emitter is second to none. Quastar’s proprietary technology provides the ability to produce a greater photon flux of higher energy x-rays while filtering the weak x-rays that cause uneven dose treatment.
Quastar’s engineering provides faster, higher quality, and more uniform dosing of the target than the standard imaging tube, and it does so more efficiently.
What’s the Difference?
Quastar vs. Nuclear
Although a reactive source, nuclear radiation has been around for years due to its ease of availability. As technology matured, experts understood and acted on the effects of gamma ionizing radiation. From its volatility to harmful byproducts and stringent licensing requirements, gamma irradiation is becoming a thing of the past.
The Department of Energy has spearheaded CIRP (Cesium Irradiator Replacement Program) – a subsidizing initiative created to replace gamma isotope-source (cesium-137 based) irradiators in the US. They provide an up-to 50% financial incentive towards the purchase of a new non-radio isotopic device as well as the removal and disposal of current irradiator – an approximate cost-reduction of more than $200 thousand dollars.
By 2025, gamma powered irradiators will become obsolete. Stay ahead of the inevitable with us as we propel our global partners to improve and enhance the quality of life.
Latest News & Studies
Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma
Medulloblastoma is a highly invasive cancer of central nervous system diagnosed mainly in children. Matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator receptor (uPAR) are over expressed in several cancers and...
Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo
Combined treatment with thioridazine and irradiation significantly reduced viability of ESCC cells compared with thioridazine or irradiation treatment alone. Thioridazine and irradiation treatment induced G0/G1 phases cell cycle...
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
The limitations of cancer cell lines have led to the development of direct patient derived xenograft (PDX) models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells...